Related Experiment Video
Updated: Mar 31, 2026
11:30
A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
2.6K
Calpains and Coronary Vascular Disease
Brittany A Potz1, Ashraf A Sabe, M Ruhul Abid
1Division of Cardiothoracic Surgery, Cardiovascular Research Center, Warren Alpert Medical School Brown University.
Summary
Calpain inhibition may offer a new medical therapy for coronary artery disease (CAD). This approach can reduce myocardial stunning and infarct size after ischemia-reperfusion injury in CAD patients.
Area of Science:
- Biochemistry
- Cardiology
- Pharmacology
Background:
- Percutaneous and surgical interventions for coronary artery disease (CAD) remain suboptimal for many patients.
- Calpains, calcium-activated cysteine proteases, are implicated in myocardial ischemia and reperfusion injury.
- Uncontrolled calpain activation contributes to cardiac hypertrophy and stunning.
Purpose of the Study:
- To explore the therapeutic potential of calpain inhibition in managing CAD.
- To investigate the role of calpains in myocardial damage during ischemia-reperfusion.
Main Methods:
- Review of existing literature on calpain function and inhibition.
- Analysis of studies demonstrating the effects of calpain inhibition on cardiac ischemia-reperfusion models.
Main Results:
- Calpain inhibition significantly attenuates myocardial stunning.
- Reduced infarct size observed in models utilizing calpain inhibition post-ischemia-reperfusion.
Conclusions:
- Calpain inhibition presents a promising therapeutic strategy for CAD.
- Targeting calpains may improve outcomes for patients with myocardial ischemia and reperfusion injury.
Related Concept Videos
01:26Coronary Artery Disease II: Pathophysiology
970
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
970
01:27Coronary Artery Disease V: Interprofessional Care
410
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
410
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.8K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.8K
01:30Angina I: Introduction
693
Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
693
01:30Coronary Artery Disease I: Introduction
1.6K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
727
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
727